Literature DB >> 14525707

[Prevention of perinatal group B streptococcal disease. Spanish revised guidelines. The Spanish Society of Obstetrics and Gynecology, The Spanish Society of Neonatology, The Spanish Society of Infectious Diseases and Clinical Microbiology, The Spanish Society of Chemotherapy, and the The Spanish Society of Family and Community Medicine].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14525707

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN： 0213-005X            Impact factor:   1.731


× No keyword cloud information.
  4 in total

Review 1.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  [16-week pregnant woman with positive urine culture for group B Streptococcus (GBS) or Streptococcus agalactiae].

Authors:  Fj Guerrero García; Im Rodríguez Bravo; R Vázquez Molina
Journal:  Aten Primaria       Date:  2005-05-31       Impact factor: 1.137

4.  Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.

Authors:  J J Gonzalez; A Andreu
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.